We established stable HeLa transformants with reporter genes containing nuclear factor (NF)-κB response elements to measure NF-κB inhibition. Tumor necrosis factor (TNF)-α treatment induced a 6-fold activation of NF-κB in HeLa NF-κB -3 cells. Three chloro-derivatives of fourteen dibenzoylmethane derivatives inhibited NF-κB activity.
INTRODUCTION
Nuclear factor-κB (NF-κB) is a dimeric transcription factor that induces expression of genes involved in the inflammatory process. In unstimulated cells, NF-κB is retained in the cytoplasm via interaction with its inhibitor, IκB. 1) In response to pro-inflammatory stimuli, IκB is phosphorylated by the IκB kinase complex, leading to its ubiquitination and subsequent proteasome-mediated degradation, allowing a dimmer of NF-κB to enter the nucleus. NF-κB then binds to its promoter recognition sequences to induce target gene transcription, including mediators of the immune and inflammatory response such as the inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-2, IL-6, and IL-8. 2) Compounds that inhibit NF-κB are of great interest as lead structures for the treatment of acute and chronic inflammation.
Diacylmethanes possess an active methylene * To whom correspondence should be addressed: Depart- 3) The diacylmethane derivative, 2,2 -dimethoxydibenzoylmethane, protects dopaminergic neurons against both endoplasmic reticulum (ER) stress and oxidative stress by preventing the formation of reactive oxygen species. 4) Here we established stable transformants with an NF-κB response element to evaluate the ability of diacylmethane derivatives to inhibit NF-κB activity.
MATERIALS AND METHODS
Materials --Dulbecco's Eagle's medium was purchased from Nissui (Tokyo, Japan). Calf serum was obtained from Boehringer Mannheim (Mannheim, Germany). Non-essential amino acids were purchased from Invitrogen (Carlsbad, CA, U.S.A.). pNF-κB-secreted alkaline phosphatase (SEAP) and pSV2-neo was purchased from BD Biosciences (San Jose, CA, U.S.A.) and the Japan Health Science Foundation (Osaka, Japan), respectively. Recombinant human TNF-α was obtained from PeproTech House (London, U.K.). Effectene TM transfection reagent was from QIA-GEN (Valencia, CA, U.S.A.). Great EscAPe SEAP Fluorescence Detection Kits were obtained from BD Biosciences. Cell Culture --HeLa cells were obtained from the Japan Health Science Foundation. Cells were cultured in Dulbecco's Eagle's medium containing 10% calf serum and 100 µM non essential amino acids at 37 • C. Stable Transformants with an NF-κB Response Element --The day before transfection, 1.5 × 10 6 HeLa cells were seeded on a 100 mm dish. pNF-κB-SEAP (0.2 µg) and pSV2-neo (2.0 µg) were co-transfected with an Effectene TM transfection reagent according to the manufacturer's protocol. After 16 hr, the medium containing plasmids was exchanged to fresh growth medium with 50 µg/ml of G418 (Nakarai Tesque, Kyoto, Japan). Cells were subcultured several times for single-cell cloning in 96-well plates. NF-κB Activity --HeLa NF-κB -3 cells (0.5 × 10 4 ) were seeded on a 96-well tissue culture plate. After 2 hr, aliquots of test sample solution were added to each well. After 1 hr, 10 µl of 800 ng/ml TNF-α was also added into 200 µl of each well. After 24 hr, media was assayed for SEAP activity according to the manufacturer's protocol.
RESULTS AND DISCUSSION
To efficiently evaluate the ability of compounds to inhibit NF-κB, we generated stable transformants of HeLa cells with an NF-κB response element containing an SEAP reporter gene. We observed TNF-α-induced activation of SEAP in 4 of 12 clones obtained by single-cell cloning (Fig. 1) , with HeLa NF-κB -3 cells showing the highest activity, 6-fold, similar to transient transfection experiments (data not shown). And 10 µg/ml of 12-O-tetradecanoylphorbol 13-acetate (TPA) also activated NF-κB of HeLa NF-κB -3 cells. Its activity was 1.1 times as high as the activity by the stimulation with TNF-α. Furthermore we confirmed that 1 µM of parthenolide, 4) a known NF-κB inhibitor, inhibited 38% of NF-κB activity using the cloned cells.
Fourteen dibenzoylmethane derivatives (1-14) synthesized by Choshi et al. were evaluated for NF-κB inhibition at 20 µM (Table 1) using HeLa NF-κB -3 cells. Compounds 3, 6, 11, and 14 showed 30%, 50%, 41%, and 27% inhibition, respectively. The structures of 1, 3, 6, 12, and 14 were substituted with fluorine (12), chlorine (3, 6, and 14) or bromine (1) of an electron-withdrawing group on two benzene rings, except for 11, but 1 (8%) and 12 (0%) were not inhibitors. Thus, the substitution by chlorine(s) and the methoxy group affected NF-κB inhibition. Compounds 6 and 11 protect dopaminergic neurons against both oxidative and ER stress, which can activate NF-κB. 5 ) Future work will involve the 
